Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 534 clinical trials
  • 0 views
  • 10 Nov, 2021
  • 1 location
  • 0 views
  • 27 Jan, 2021
  • 20 locations
A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients

(Albumin Bound) for advanced solid tumors of patients. To explore the reasonable dosage of dosage regimen of combination therapy for advanced malignant tumors of patients.

  • 0 views
  • 27 Apr, 2022
  • 1 location
Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

The purpose of this study is to evaluate the efficacy and safety of camrelizumab and apatinib as combination therapy in patients with ultra high-risk (Cohort A) and high-risk chemo-refractory or

  • 0 views
  • 22 Jul, 2022
  • 1 location
  • 0 views
  • 16 May, 2022
  • 1 location
EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone

The purpose of this study is to evaluate the efficacy of combination therapy with omeprazole and swallowed fluticasone vs fluticasone therapy and placebo in the treatment of Eosinophilic

  • 0 views
  • 22 Jan, 2021
  • 1 location
Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma

This study is to investigate safety and feasibility of a combination therapy of a tumor infiltrating lymphocytes (TIL) transfer with anti-programmed cell death protein (PD)-1 therapy in patients

liver metastasis
platelet count
gilbert's syndrome
nivolumab
metastatic melanoma
  • 0 views
  • 14 Aug, 2021
  • 1 location
  • 6 views
  • 16 Oct, 2021
  • 2 locations
NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL

The purpose of this study is to determine the feasibility, safety, and efficacy of a combination therapy in the treatment of B-cell acute lymphoblastic leukemia (B-ALL) based on multi-antigen

  • 0 views
  • 13 Mar, 2022
  • 1 location
HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer

and PD-L1 CPS≥5 ) will receive HLX07 combination therapy with HLX10 and chemotherapy (oxaliplatin+capecitabine) as first-line treatment. Arm B will receive HLX07 monotherapy as third-line or above

  • 0 views
  • 16 May, 2022
  • 2 locations